Objective and Subjective COVID-19 Vaccine Reactogenicity by Age and Vaccine Manufacturer
David M Presby, Emily R Capodilupo
doi: https://doi.org/10.1101/2021.04.29.21256255
David M Presby
1Whoop, Inc., Department of Data Science and Research, Boston, Massachusetts
Emily R Capodilupo
1Whoop, Inc., Department of Data Science and Research, Boston, Massachusetts

Article usage
Posted April 30, 2021.
Objective and Subjective COVID-19 Vaccine Reactogenicity by Age and Vaccine Manufacturer
David M Presby, Emily R Capodilupo
medRxiv 2021.04.29.21256255; doi: https://doi.org/10.1101/2021.04.29.21256255
Subject Area
Subject Areas
- Addiction Medicine (427)
- Allergy and Immunology (753)
- Anesthesia (220)
- Cardiovascular Medicine (3281)
- Dermatology (274)
- Emergency Medicine (478)
- Epidemiology (13336)
- Forensic Medicine (19)
- Gastroenterology (896)
- Genetic and Genomic Medicine (5127)
- Geriatric Medicine (479)
- Health Economics (780)
- Health Informatics (3250)
- Health Policy (1137)
- Hematology (427)
- HIV/AIDS (1012)
- Medical Education (475)
- Medical Ethics (126)
- Nephrology (521)
- Neurology (4898)
- Nursing (261)
- Nutrition (725)
- Oncology (2515)
- Ophthalmology (722)
- Orthopedics (280)
- Otolaryngology (346)
- Pain Medicine (323)
- Palliative Medicine (90)
- Pathology (537)
- Pediatrics (1297)
- Primary Care Research (554)
- Public and Global Health (7482)
- Radiology and Imaging (1700)
- Respiratory Medicine (979)
- Rheumatology (478)
- Sports Medicine (424)
- Surgery (545)
- Toxicology (71)
- Transplantation (235)
- Urology (203)